FOXP3 and breast cancer: Furthermore, in their study, the CD8+/FOXP3 ratio was shown to be linked to recurrence-free survival (RFS) and BC specific survival: a high CD8+/FOXP3+ ratio entails a higher RFS and BCS [44].